COVID-19 and Epilepsy
If you have questions — or important information to share — about management of people with epilepsy in relation to COVID-19, email us here
COVID-19 Vaccines and people with Epilepsy
Available in English, Arabic, Chinese (both mainland and traditional), Farsi, French, German, Italian, Japanese, Russian, Spanish, and Swahili
COVID-19 vaccines and people with epilepsy in all languages
ILAE COVID-19 and Epilepsy Research Award
We are pleased to announce the 2020 winners of the ILAE COVID-19 and Epilepsy Research Award, for the best research undertaken during the COVID19 pandemic, published or in press, for COVID-19 and epilepsy.
We will offer further COVID-19 project prizes, one available per region. All are encouraged to apply, but we particularly encourage early career researchers.
To submit your research for consideration, please send your research reference (one paper only, please) and your affiliations to email@example.com. Applications are due before 31 August 2021.
Learnings from the COVID Pandemic: The New Normal
Opportunities to gain insights from ILAE experts, learn more about current best practices, and understand how the pandemic will likely affect medical practice into the future. View the recorded symposium and the 10-minute microlearning modules based on key concepts.
If you have cared for a patient who has experienced an exacerbation of seizures, developed new onset seizures, or experienced another neurological change, please add the case information to our dataset.
Surveys and FAQs for patients and clinicians are available in up to 10 languages other than English. Select one of the sections above to begin!
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community